Brainsway Ltd. BWAY

Latest FY: 2025 Healthcare Medical Devices
Market Price $16.34
Market Cap $643.49M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑27.3% YoY
$52.23M
3-Yr CAGR: 24.3%
Net Income ↑122.9% YoY
$7.71M
Net Margin: 14.8%
Free Cash Flow ↓-202.5% YoY
-$2.64M
FCF Yield: -0.41%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
1,793.0%
ROA: 6.8%
⚡ Elevated ROE due to low book equity from buybacks

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (BWAY)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016
FY 2017 $11.1M $8.6M $6.6M $-0.1M $-0.5M
FY 2018 $16.4M +47.1% $12.8M $-6.3M -194.8% $0.0M $-0.2M +53.7%
FY 2019 $23.1M +40.9% $18.0M $-9.9M -58.0% $0.2M $-0.0M +96.7%
FY 2020 $22.1M -4.5% $17.0M $-5.1M +48.0% $0.1M $0.0M +575.0%
FY 2021 $29.7M +34.5% $23.1M $-6.4M -24.7% $0.0M $-2.2M -5,944.7%
FY 2022 $27.2M -8.4% $20.0M $-13.0M -103.1% $1.0M $-0.9M +59.7%
FY 2023 $31.8M +17.0% $23.5M $-3.9M +69.7% $1.7M $-0.7M +23.9%
FY 2024 $41.0M +29.0% $30.6M $3.5M +187.7% $2.9M $-0.9M -28.2%
FY 2025 $52.2M +27.3% $39.4M $7.7M +122.9% $-0.3M $-2.6M -202.5%
$

Valuation

Market Price $16.34
Market Cap $643.49M
Enterprise Value $588.35M
P/E Ratio N/A
P/B Ratio 1,488.30
FCF Yield -0.41%
Dividend Yield N/A
Shares Outstanding 39,165,806
%

Profitability & Margins

Gross Margin 75.42%
Operating Margin 36.25%
Net Margin 14.76%
Return on Equity (ROE) 1,793.02%
Return on Assets (ROA) 6.81%
Asset Turnover 0.46x
Revenue 3-Yr CAGR 24.33%
🛡️

Financial Health & Liquidity

Current Ratio 4.84
Cash Ratio 3.86
Debt / Equity 29.207
Debt / Assets 0.111
Cash & Equivalents $67.70M
Total Debt $12.56M
Book Value / Share $0.01
💧

Cash Flow Efficiency

Operating Cash Flow -$298.00K
Capital Expenditures (CapEx) $2.34M
Free Cash Flow -$2.64M
OCF / Revenue -0.57%
FCF / Revenue -5.05%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $0.01
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $113.19M
Total Liabilities $39.70M
Stockholders' Equity $430.00K
Current Assets $84.89M
Current Liabilities $17.53M